InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Goodman Jonathan R., 董事. Insider active across 1 company, notably POINT Biopharma Global Inc.. Aggregated, 4 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €37k. History available since 18 November 2022. The latest transaction was disclosed on 18 November 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Jonathan R. Goodman is a Board Member at Point Biopharma Global Inc. He is responsible for overseeing the company's strategies and regulatory compliance. His experience in the biopharmaceutical sector is a valuable asset to the board.